2002
DOI: 10.1254/jjp.88.341
|View full text |Cite
|
Sign up to set email alerts
|

Electrophysiological, Anatomical and Histological Remodeling of the Heart to AV Block Enhances Susceptibility to Arrhythmogenic Effects of QT-Prolonging Drugs

Abstract: ABSTRACT-The present study was designed to investigate what kinds of adaptation occurred in the canine chronic AV block model, which has been used to study torsade de pointes (TdP). Dogs at 7 -10 days (acute phase) and 28 -56 days (chronic phase) after AV block were assessed. Ventricular effective refractory period and monophasic action potential duration were prolonged in chronic animals compared with acute animals; moreover the electrically vulnerable period was prolonged in chronic animals. Non-specific IKr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
54
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 60 publications
(56 citation statements)
references
References 25 publications
2
54
0
Order By: Relevance
“…Experiments are now on-going to demonstrate that hypothesis using canine complete atrioventricular conduction block models in which HR can be controlled by ventricular pacing over 40-200 beats/min. 32 On the other hand, mexiletine shortened the MAP90, but prolonged the ERP, resulting in the disappearance of TRP, which could prevent premature excitation with its associated conduction slowing. 14 These differences in the electrophysiological profiles of these drugs might explain their clinically described antiarrhythmic and proarrhythmic effects.…”
Section: Effects On the Terminal Repolarization Phasementioning
confidence: 99%
“…Experiments are now on-going to demonstrate that hypothesis using canine complete atrioventricular conduction block models in which HR can be controlled by ventricular pacing over 40-200 beats/min. 32 On the other hand, mexiletine shortened the MAP90, but prolonged the ERP, resulting in the disappearance of TRP, which could prevent premature excitation with its associated conduction slowing. 14 These differences in the electrophysiological profiles of these drugs might explain their clinically described antiarrhythmic and proarrhythmic effects.…”
Section: Effects On the Terminal Repolarization Phasementioning
confidence: 99%
“…Most of the torsadogenic drugs have been shown to inhibit a rapid component of delayed rectifier K + channels (I Kr ) encoded by the human ether-a-go-go-related gene (hERG) (1, 2). Indeed, a histamine H 1 -blocker terfenadine and a gastrokinetic drug cisapride are known as non-cardiovascular torsadogenic drugs, both of which are now clinically unavailable for patients (3,4). In 2004, clobutinol, a common over-the-counter antitussive drug, was reported to induce torsades de pointes in a young patient via inhibition of hERG K + channels (5,6), and then the drug was withdrawn from the worldwide market in 2007 after subsequent clinical investigations.…”
Section: Introductionmentioning
confidence: 99%
“…Arrhythmogenic substrates in the chronic atrioventricular block dogs have been analyzed by in vitro single cell experiments and in vivo electrophysiological examinations in addition to the anatomical and histological assessments, in which downregulation of K channels and prolongation of the QT interval together with cellular hypertrophy and interstitial fibrosis were demonstrated (6,7,12). Furthermore, trigger of arrhythmias including early afterdepolarization can be spontaneously induced by QT-interval-prolonging drugs via the increase of temporal dispersion of repolarization, leading to generation of ventricular tachyarrhythmias like torsades de pointes (6,10).…”
Section: Introductionmentioning
confidence: 99%